Compare GROW & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GROW | ARAY |
|---|---|---|
| Founded | 1968 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 31.3M |
| IPO Year | 1995 | 2006 |
| Metric | GROW | ARAY |
|---|---|---|
| Price | $3.01 | $0.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 20.9K | ★ 402.7K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | ★ 900.00 | 87.50 |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $14,399,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.58 |
| P/E Ratio | $12.50 | ★ N/A |
| Revenue Growth | ★ 32.77 | N/A |
| 52 Week Low | $2.23 | $0.22 |
| 52 Week High | $3.65 | $2.10 |
| Indicator | GROW | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | N/A |
| Support Level | $2.86 | N/A |
| Resistance Level | $3.05 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 30.65 | 0.00 |
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.